HuagongsheHuagongshe Chemistry Print Report · For research reference only
Magnesium orthosilicate → N-[4-(5H-Pyrrolo[2,1-c][1,4]benzodiazepine-10(11H)-ylcarbonyl)phenyl]-2-(phenylmethyl)benzamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Magnesium orthosilicate | HCID 66225 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | 10,11-Dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine | HCID 15547048 | — |
| Reactant | 4-[[2-(Phenylmethyl)benzoyl]amino]benzoyl Chloride | HCID 22099663 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | N-[4-(5H-Pyrrolo[2,1-c][1,4]benzodiazepine-10(11H)-ylcarbonyl)phenyl]-2-(phenylmethyl)benzamide | HCID 18917517 | 97.3% |
Reaction Steps
To a solution of 0.75 g of 10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine and 0.57 g of N,N-diisopropylethylamine in 50 ml of methylene chloride is added 1.53 g of 4-[[2-(phenylmethyl)benzoyl]amino]benzoyl chloride followed by stirring at room temperature for 18 hours. The reaction mixture is washed with water and saturated aqueous NaHCO3 and the organic layer dried (Na2SO4). The organic layer is passed through hydrous magnesium silicate and the filtrate concentrated in vacuo to give a residue which is dissolved in methylene chloride and passed through hydrous magnesium silicate two additional times to give upon concentration in vacuo to give 1.97 g of the desired product as an amorphous solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US05612334 |
| Source dataset | uspto-grants-1997_03 |
| ORD ID | ord-cab47b35168d40469b92340e7a6c29c6 |
| Source note | uspto-grants-1997_03 |